WCG

WCG accelerates clinical research by bringing together deep expertise, scale, and collaboration across the global clinical trials ecosystem. The company partners with more than 5,000 biopharma and CRO clients, including all of the top 50 pharmaceutical companies and all top eight CROs, as well as over 3,400 institutions and academic medical centers. Its network includes more than 250,000 investigators, 300,000 research sites, 80,000 clinical research coordinators, over 2.5 million participants in WCG-supported studies, and more than 100 patient advocacy groups. WCG’s impact is reflected in the fact that 94% of FDA-approved therapeutic agents in the past five years were supported by WCG, with more than 4,000 clinical trials supported in the last year across 130+ countries. The company employs over 1,300 people in 12 countries and brings more than 55 years of leadership in independent ethical review.

WCG’s approach is built on deep, cross-therapeutic expertise and trusted partnerships. Its experience and know-how span all therapeutic areas and are applied where and when partners need them most. By seamlessly connecting sponsors, CROs, research sites, investigators, coordinators, and participants, WCG ensures that the right stakeholders are aligned to the right studies. This insight-driven, collaborative model helps reduce friction across the clinical research process and enables partners to deliver life-saving therapies to patients faster.

WCG also delivers actionable insights through data intelligence developed from decades of experience. By turning 55 years of clinical research expertise into analytics-driven intelligence, WCG supports decisions based on data rather than opinion. These insights help partners optimize study design, execution, and oversight, resulting in faster trials, reduced risk, and better outcomes across the clinical research lifecycle.